ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,040.53
      -0.50%
      US Tech 100
      20,818.00
      -0.50%
      Dow Jones
      44,544.66
      -0.75%
      Brent Oil
      76.385
      0.00%
      Bitcoin
      102,521.29
      0.10%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Viracta Therapeutics Inc (VIRX) Quote

      Viracta Therapeutics Inc

      Viracta Therapeutics Inc (VIRX)

      NASDAQ
      0.1515
      -0.0037
      (-2.38%)
      Closed January 31 4:00PM
      Delayed by 15 minutes
      0.0748
      -0.0767
      (-50.63%)
      After Hours: 7:53PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.0748
      Bid
      0.0724
      Ask
      0.0749
      Volume
      2,347,368
      0.1475 Day's Range 0.1587
      0.056 52 Week Range 1.31
      Market Cap
      2.973M
      Previous Close
      0.1552
      Open
      0.1475
      Last Trade
      1000
      @
      0.0748
      (formt)
      Last Trade Time
      Financial Volume
      $ 356,305
      VWAP
      0.151789
      Average Volume (3m)
      2,397,029
      Shares Outstanding
      39,744,222
      Dividend Yield
      -
      PE Ratio
      -0.12
      Earnings Per Share (EPS)
      -1.28
      Revenue
      -
      Net Profit
      -51.06M

      About Viracta Therapeutics Inc

      Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein... Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.viracta.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Viracta Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VIRX. The last closing price for Viracta Therapeutics was $0.16. Over the last year, Viracta Therapeutics shares have traded in a share price range of $ 0.056 to $ 1.31.

      Viracta Therapeutics currently has 39,744,222 shares outstanding. The market capitalization of Viracta Therapeutics is $6.17 million. Viracta Therapeutics has a price to earnings ratio (PE ratio) of -0.12.

      Ask ADVFN Intelligence (AI)

      VIRX Latest News

      More News

      Form 8-K - Current report

      4 hours ago
      Edgar (US Regulatory)

      Form 8-K - Current report

      January 24 2025
      Edgar (US Regulatory)

      Form 8-K - Current report

      January 17 2025
      Edgar (US Regulatory)

      Form 8-K - Current report

      December 26 2024
      Edgar (US Regulatory)

      Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives

      SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated...

      December 26 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      November 29 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 27 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 22 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 13 2024
      Edgar (US Regulatory)

      Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

      - Reprioritized resources to reduce costs and enhance focus on Nana-val’s development program in relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) - - On track to report data...

      November 13 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.0847-53.10344827590.15950.18450.0564692830.16394876CS
      4-0.1-57.20823798630.17480.23890.05617162320.19981948CS
      12-0.1052-58.44444444440.180.2574060.05623970290.18027402CS
      26-0.3952-84.0851063830.470.560.05617515290.21612787CS
      52-0.4352-85.33333333330.511.310.0569354580.24630262CS
      156-2.3352-96.89626556022.415.750.0564269360.82247767CS
      260-16.6852-99.55369928416.7618.240.0563888772.12994846CS

      VIRX - Frequently Asked Questions (FAQ)

      What is the current Viracta Therapeutics share price?
      The current share price of Viracta Therapeutics is $ 0.0748
      How many Viracta Therapeutics shares are in issue?
      Viracta Therapeutics has 39,744,222 shares in issue
      What is the market cap of Viracta Therapeutics?
      The market capitalisation of Viracta Therapeutics is USD 6.17M
      What is the 1 year trading range for Viracta Therapeutics share price?
      Viracta Therapeutics has traded in the range of $ 0.056 to $ 1.31 during the past year
      What is the PE ratio of Viracta Therapeutics?
      The price to earnings ratio of Viracta Therapeutics is -0.12
      What is the reporting currency for Viracta Therapeutics?
      Viracta Therapeutics reports financial results in USD
      What is the latest annual profit for Viracta Therapeutics?
      The latest annual profit of Viracta Therapeutics is USD -51.06M
      What is the registered address of Viracta Therapeutics?
      The registered address for Viracta Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
      What is the Viracta Therapeutics website address?
      The website address for Viracta Therapeutics is www.viracta.com
      Which industry sector does Viracta Therapeutics operate in?
      Viracta Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TCTMTCTM Kids IT Education Inc
      $ 0.764
      (321.87%)
      		730.95M
      REBNReborn Coffee Inc
      $ 3.31
      (63.05%)
      		55.53M
      FCUVFocus Universal Inc
      $ 5.87
      (56.62%)
      		1.73M
      SOPASociety Pass Inc
      $ 1.54
      (56.50%)
      		13.77M
      CYCNCyclerion Therapeutics Inc
      $ 3.92
      (54.33%)
      		82.54M
      ENVBEnveric Biosciences Inc
      $ 2.0899
      (-46.41%)
      		1.58M
      NIVFNewGenIvf Group Ltd
      $ 0.1489
      (-42.51%)
      		14.91M
      GLSTGlobal Star Acquisition Inc
      $ 8.83
      (-39.10%)
      		23.93k
      PRPHProPhase Labs Inc
      $ 0.2633
      (-38.02%)
      		898.81k
      SPGCSacks Parente Golf Inc
      $ 0.5601
      (-37.86%)
      		7.4M
      TCTMTCTM Kids IT Education Inc
      $ 0.764
      (321.87%)
      		730.95M
      NVDANVIDIA Corporation
      $ 120.07
      (-3.67%)
      		388.05M
      RIMEAlgorhythm Holdings Inc
      $ 0.02565
      (5.12%)
      		338.45M
      CLEUChina Liberal Education Holdings Ltd
      $ 0.1938
      (30.77%)
      		236.37M
      BHATBlue Hat Interactive Entertainment Technology
      $ 0.0355
      (-11.25%)
      		232.56M

      VIRX Discussion

      View Posts
      glenn1919 glenn1919 2 months ago
      VIRX.................................https://stockcharts.com/h-sc/ui?s=VIRX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Invest-in-America Invest-in-America 2 months ago
      VIRX: Up 35% in the Post-M today. (28-Mil. Float)
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      VIRX DILUTION HITTING HARD
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      VIRX ON THE MOVE
      👍️0
      Monksdream Monksdream 6 months ago
      VIRX new 52 week low
      👍️0
      glenn1919 glenn1919 6 months ago
      VIRX..............................................https://stockcharts.com/h-sc/ui?s=VIRX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Awl416 Awl416 6 months ago
      Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan
      👍️0
      glenn1919 glenn1919 10 months ago
      VIRX......................https://stockcharts.com/h-sc/ui?s=VIRX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 10 months ago
      VIRX under $2
      👍️0
      Monksdream Monksdream 1 year ago
      VIRX new 52 week low
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      https://stockcharts.com/h-sc/ui?s=virx&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      nice
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      lil dip
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      soon
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      https://www.barchart.com/stocks/quotes/VIRX/technical-chart?plot=BAR&volume=total&data=I:120&density=H120&pricesOn=1&asPctChange=0&logscale=0&im=120&indicators=EXPMA(9);SMA(20);BBANDS(20,2);MACD(12,26,9)&sym=VIRX&grid=1&height=500&studyheight=100
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      rip
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      reasy
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      nice
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      dip
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      dip
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      nice
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      ready
      👍️0
      Triple nickle Triple nickle 2 years ago
      Break 1.81 and it’s boomage imo
      👍️0
      Triple nickle Triple nickle 2 years ago
      Could break out at 1.68 folks
      👍️0
      AOuvier AOuvier 3 years ago
      $VIRX- Took a starter position @ $5.01 today. Partial Order filled
      👍️0
      TheSilverFox121 TheSilverFox121 4 years ago
      WOW
      👍️0
      TheSilverFox121 TheSilverFox121 4 years ago
      Great to see some upwards strength! GLTA
      👍️0
      TheSilverFox121 TheSilverFox121 4 years ago
      I just bought in at 9.07 GLTA
      👍️0
      trity trity 4 years ago
      buy buy buy!!!!
      👍️0
      trity trity 4 years ago
      don't sell hold on to those shares
      👍️0
      trity trity 4 years ago
      fda may approve
      👍️0
      trity trity 4 years ago
      big news coming
      👍️0
      trity trity 4 years ago
      stock will jump big today
      👍️0
      John_Langston John_Langston 4 years ago
      Thanks
      👍️0
      Dspetry Dspetry 4 years ago
      On February 24, 2021, and in connection with the closing of the merger, Sunesis effected a 1-for-3.5 reverse stock split. All issued and outstanding shares of common stock of Sunesis were subject to the reverse stock split.
      👍️0
      John_Langston John_Langston 4 years ago
      What was the RS 1 for 3?
      👍️0
      Jconwon Jconwon 4 years ago
      Not even on anyone's radar. 16.25-18. rough 10% with almost no volume. Morning trade is good but hard to really predict these things.
      👍️0

      Your Recent History

      NASDAQ
      VIRX
      Viracta Therapeutics
      BIT
      S29109
      Societe Generale Effekten
      BIT
      F28927
      Vontobel Financial Produ...
      BIT
      F33144
      Vontobel Financial Produ...
      BIT
      UC6M38
      Unicredit Bank
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads